Tuesday, October 15, 2024
6:45 BREAKFAST
Workshop A, Session 1: Data Science and Artificial Intelligence
8:15 Rising T1DE Alliance and D-Data Dock: Transforming Care via Integration of CGM and Other Clinical Data
Mark A. Clements, MD, PhD, CPI, FAAP
Children’s Mercy Hospital, Kansas City, Missouri, USA
8:30 AI Technologies in Enhancing Treatment of Diabetes
Ali Cinar, PhD
Illinois Institute of Technology, Chicago, Illinois, USA
8:45 Digital Twins in T1D Therapy: Practical Applications and Benefits
Andrea Facchinetti, PhD
Department of Information Engineering, University of Padova, Padova, Italy
9:00 AI-enabled Dual-Hormone Pramlintide and Insulin MPC Control Algorithm and In-Silico Results
Peter G. Jacobs, PhD
Oregon Health & Science University, Portland, Oregon, USA
9:15 Integrating AI and Machine Learning for Prediabetes: Predictive Models and Intervention Strategies for Early Diagnosis and Management
Nestoras Mathioudakis, MD
Johns Hopkins University, Baltimore, MD
9:30 Q&A
9:45 BREAK
Workshop A, session 2: Real World Evidence for Diabetes Trials
10:15 Aviation Medicine for People with Diabetes
Renald Meçani
10:30 Real World Evidence Applied to Clinical Care
Julia K. Mader, MD
Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Austria
10:45 Harnessing University of California Health Data Warehouse to Learn Effective and Safe Treatments in Type 2 Diabetes
Rohit Vashisht, PhD
University of California, San Francisco, San Francisco, California, USA
11:00 How Diabetes Research Hub (DRH) Modernizes and Enhances RWE Utilization
Shahid N. Shah, M.Sc.
Netspective Communications, Silver Spring, Maryland, USA
11:15 Panel Discussion
11:45 LUNCH
Workshop B, Session 1: New Diagnostic Tests
13:15 Current Research Programs at Breakthrough T1D
Aaron Kowalski, PhD
Breakthrough T1D, New York City, New York, USA
13:30 Antibodies to Diagnose Diabetes
Zoe Quandt, MD
Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, California, USA
13:45 Continuous Insulin Monitoring
Joseph Wang, PhD
University of California, San Diego, San Diego, California, USA
14:00 Cardiac Blood Pressure and Exercise Monitoring
Ambarish Pandey, MD
UT Southwestern Medical Center, Dallas, Texas, USA
14:15 Qualitative Hypoglycemia Detection
Gerard L. Coté, PhD
Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA
14:30 Q&A
14:40 BREAK
Workshop B, Session 2: Drugs, Insulin and Technology
15:10 Storage of Insulin
Lutz Heinemann, PhD
Science Consulting in Diabetes, Düsseldorf, Germany
15:25 Use of GLP-1 RAs Before Surgery
Sun H. Kim, MD
Department of Medicine – Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine, Stanford, California, USA
15:40 Solutions for Age-Related and Drug-Induced Muscle Loss: A Major Public Health Problem
Zan Fleming, MD
Kinexum, Harpers Ferry, West Virginia, USA
15:55 Vertex Type 1 Diabetes Clinical Trials
Jean-Marc Guettier, MD
Vertex Pharmaceuticals, Boston, MA, USA
16:10 Insulin Pump Therapy in the Hospital
Robert J. Rushakoff, MD
University of California, San Francisco, San Francisco, CA, USA
16:25 Q&A
16:30 Poster Session
Wednesday, October 16, 2024
6:30 BREAKFAST
8:00 Welcome and Introduction
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
8:05 Keynote Presentation - How is the FDA OIVD evolving to regulate new technologies?
Anthony Maiorana, PhD
Diabetes Branch, U.S. Food and Drug Administration, Silver Spring, Maryland, USA
Session 1: HOW BIG TECH SEES DIABETES
8:30 Panelists
Erich Huang, MD, PhD
Verily, South San Francisco, California, USA
Alyssa Patel, PharmD, BCACP
Clinical Pharmacist, Chronic Care, One Medical, San Francisco, California, USA
Aiman Abdel-Malek, PhD
Thirdwayv Inc. and Apex Medical Ai Inc., La Jolla, CA
Praveen Raja, PhD
Samsung Research America
8:35 Panel Discussion
9:40 BREAK
Session 2: New Uses of CGMs
10:10 Nutrition Monitoring for Diabetes
David Kerr, MBChB, DM, FRCP, FRCPE
Sutter Health, Santa Barbara, California, USA
10:25 Use of CGMs by Elite Athletes
Howard Zisser, MD
University of California Santa Barbara, Santa Barbara, CA, USA
10:40 CGM for Prediabetes
Michael P. Snyder, PhD
Department of Genetics, Stanford University, Palo Alto, California, USA
10:55 Q&A
Session 3: Who Can Sell Your Data
11:05 An Oceania Perspective
Geoff Chase, PhD
University of Canterbury, Christchurch, New Zealand
11:20 An FTC Regulatory Perspective
Jamie E. Darch, JD
Ropes & Gray LLP, Chicago, Illinois, USA
11:35 A United States Perspective
Bonnie Odom, JD, MPH
Epstein Becker & Green, P.C., San Diego, California, USA
11:50 Q&A
12:00 LUNCH
Session 4: Payers/Economics for Digital Health Interventions
13:30 Panelists
Amanda Adler, MD, PhD, FRCP
Oxford Centre for Diabetes Endocrinology and Metabolism, Oxford, United Kingdom
Jessie Juusola, PhD
Anchor Outcomes, San Francisco, CA, USA
Jordan Silberman, MD, PhD
Elevance Health, Palo Alto, CA, USA
Paul Radensky, MD, JD
McDermott Will & Emery/McDermott+, Washington, DC, USA
13:35 Panel Discussion
Session 5: Analyzing Data from a CGM
14:30 Time in Tight Range
Peter Calhoun, PhD
Jaeb Center for Health Research, Tampa, Florida, USA
14:42 Diagnostic CGM: Analytics allowing CGM-based differentiation of diabetes stages and treatments
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA
14:54 Glycemia Risk Index
Viral N. Shah, MD
Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, Indiana, USA
15:06 Interpreting CGM Data with the Glycemia Risk Index
Ralph Oiknine, MD
Diabetes & Endocrinology Specialists Inc, Chesterfield, Missouri, USA
15:18 Q&A
15:30 BREAK
Session 6: How to Improve Artificial Pancreas Performance
16:00 Incorporating Exercise into Closed Loop Algorithms
Peter G. Jacobs, PhD
Oregon Health & Science University, Portland, Oregon, USA
16:12 Female Fertility and AID performance: Menses and Pregnancy
Carol Levy, MD, CDCES
Division of Endocrinology, Diabetes, and Metabolism, Icahn School of Medicine at Mount Sinai, New York City, New York, USA
16:24 Bihormonal Closed Loop Control
Steven J. Russell, MD, PhD
Massachusetts General Hospital Diabetes Research Center, Boston, Massachusetts, USA
16:36 The Use of GLP-1RAs with AIDs
Viral N. Shah, MD
Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, Indiana, USA
16:48 Q&A
17:00 Poster Session
Thursday, October 17, 2024
6:30 BREAKFAST
Session 7: HOW Tech can Improve Adherence to Diabetes Rx
8:00 TBD
TBD
8:12 Using Behavioural Science and Design Thinking to Develop more Engaging Digital Diabetes Innovations
Paula Voorheis, PhD
Science of Care Institute, Sinai Health System, Toronto, ON, CAN
8:24 Three key technologies that improve adherence among diabetes patients within the Los Angeles General Medical Center, the largest medical center in the Los Angeles County Health Care System
Wei-An (Andy) Lee, DO
Los Angeles General Medical Center, Los Angeles, California, USA
8:36 How Technology Enhances Patient Engagement
William Polonsky, PhD
Behavioral Diabetes Institute & University of California, San Diego, San Diego, California, USA
8:48 Q&A
Session 8: Accuracy of Diabetes Devices
9:00 The New DTS Error Grid and Trend Accuracy Matrix
Michael Kohn, MD, MPP
University of California, San Francisco, San Francisco, California, USA
9:15 Reliability and Comparability of CGM Performance Endpoints
Guido Freckmann, MD
Institute for Diabetes Technology at Ulm University, Ulm, Germany
9:30 Limitations of Using the MARD for Accuracy
Jan Krouwer, PhD
Krouwer Consulting, Sherborn, MA
9:45 Q&A
9:55 BREAK
Session 9: Innovation Challenge
10:25 Open DCB Innovation Challenge
Diabetes Center Berne, Berne, Switzerland
11:30 LUNCH
Session 10: Physiology of Inserted and Implanted Devices (non-accredited)
1:00 The Science of Extended Wear Infusion Sets
Rayhan Lal, MD
Stanford University, Palo Alto, CA, USA
13:12 Update on Optical Glucose Measurement
Mark A. Arnold, PhD
The University of Iowa, Iowa City, Iowa, USA
13:24 The DERMIS Study: What Does Insulin Pump Therapy do to the Skin, and Where Do We Go From Here?
Irl B. Hirsch, MD
University of Washington, Seattle, Washington, USA
13:36 The Technology Behind Continuous Blood Glucose Monitoring
Mark Tapsak, PhD
Glucotrack, Rutherford, New Jersey, USA
13:48 Q&A
Session 11: NEW developments in cgm products (non-accredited)
14:00 Update from Abbott
Marc Taub, PhD
Abbott Diabetes Care, Chicago, Illinois, USA
14:10 Update from Dexcom
Jessica Castle, MD
Dexcom, Inc, San Diego, California, USA
14:20 Update from Medtronic
Lou Lintereur, MS
Medtronic Diabetes, Los Angeles, CA, USA
14:30 Update from Roche
Timor Glatzer, PhD
Roche Diabetes Care, Inc, Indianapolis, Indiana, USA
14:40 Update from Senseonics
Hari Sree, PhD
Senseonics Inc., Germantown, Maryland, USA
14:50 Q&A
15:00 BREAK
Session 12: Hot Topics
15:30 ChatGPT Applied to Diabetes
Sultan A. Meo, MBBS, Ph.D, MMed Ed, FRCP
College of Medicine, King Saud University, Riyadh, Saudi Arabia
15:45 Green Diabetes Project
Lutz Heinemann, PhD
Science Consulting in Diabetes, Düsseldorf, Germany
16:00 Use of CGMs in People without Diabetes
Tracey McLaughlin, MD, MPH
Stanford School of Medicine
16:15 Continuous Glucose Monitoring (CGM)-Based Titration of Once-Weekly Insulin Icodec in Insulin-Naïve Individuals with Type 2 Diabetes (ONWARDS 9)
Richard Bergenstal, MD
International Diabetes Center, Minneapolis, MN, USA
Session 13: Live Demonstration
16:35 OneStep Foot Scanner
Chris Sandroussi
Bluedrop Medical